Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

[The new challenge in oncology: Next-generation sequencing and its application in precision medicine].

Calabria I, Pedrola L, Berlanga P, Aparisi MJ, Sánchez-Izquierdo D, Cañete A, Cervera J, Millán JM, Castel V.

An Pediatr (Barc). 2016 Nov;85(5):273.e1-273.e7. doi: 10.1016/j.anpedi.2016.05.006. Epub 2016 Jun 24. Review. Spanish.

2.

miRNAs Regulation and Its Role as Biomarkers in Endometriosis.

Marí-Alexandre J, Sánchez-Izquierdo D, Gilabert-Estellés J, Barceló-Molina M, Braza-Boïls A, Sandoval J.

Int J Mol Sci. 2016 Jan 13;17(1). pii: E93. doi: 10.3390/ijms17010093. Review.

3.

Single-nucleotide polymorphism array-based karyotyping of acute promyelocytic leukemia.

Gómez-Seguí I, Sánchez-Izquierdo D, Barragán E, Such E, Luna I, López-Pavía M, Ibáñez M, Villamón E, Alonso C, Martín I, Llop M, Dolz S, Fuster O, Montesinos P, Cañigral C, Boluda B, Salazar C, Cervera J, Sanz MA.

PLoS One. 2014 Jun 24;9(6):e100245. doi: 10.1371/journal.pone.0100245. eCollection 2014.

4.

MicroRNA expression profile in endometriosis: its relation to angiogenesis and fibrinolytic factors.

Braza-Boïls A, Marí-Alexandre J, Gilabert J, Sánchez-Izquierdo D, España F, Estellés A, Gilabert-Estellés J.

Hum Reprod. 2014 May;29(5):978-88. doi: 10.1093/humrep/deu019. Epub 2014 Mar 6.

PMID:
24608518
5.

Assessing an improved protocol for plasma microRNA extraction.

Moret I, Sánchez-Izquierdo D, Iborra M, Tortosa L, Navarro-Puche A, Nos P, Cervera J, Beltrán B.

PLoS One. 2013 Dec 23;8(12):e82753. doi: 10.1371/journal.pone.0082753. eCollection 2013.

6.

MicroRNA signatures in hereditary breast cancer.

Murria Estal R, Palanca Suela S, de Juan Jiménez I, Egoavil Rojas C, García-Casado Z, Juan Fita MJ, Sánchez Heras AB, Segura Huerta A, Chirivella González I, Sánchez-Izquierdo D, Llop García M, Barragán González E, Bolufer Gilabert P.

Breast Cancer Res Treat. 2013 Nov;142(1):19-30. doi: 10.1007/s10549-013-2723-7. Epub 2013 Oct 16.

PMID:
24129975
7.

Heart failure entails significant changes in human nucleocytoplasmic transport gene expression.

Molina-Navarro MM, Roselló-Lletí E, Tarazón E, Ortega A, Sánchez-Izquierdo D, Lago F, González-Juanatey JR, García-Pavía P, Salvador A, Montero JA, Portolés M, Rivera M.

Int J Cardiol. 2013 Oct 3;168(3):2837-43. doi: 10.1016/j.ijcard.2013.03.192. Epub 2013 May 4.

PMID:
23651824
8.

Genomic abnormalities acquired in the blastic transformation of splenic marginal zone B-cell lymphoma.

Martinez-Climent JA, Sanchez-Izquierdo D, Sarsotti E, Blesa D, Benet I, Climent J, Vizcarra E, Marugan I, Terol MJ, Sole F, Cigudosad JC, Siebert R, Dyer MJ, García-Conde J.

Leuk Lymphoma. 2003 Mar;44(3):459-64.

PMID:
12688315
9.

MALT1 is deregulated by both chromosomal translocation and amplification in B-cell non-Hodgkin lymphoma.

Sanchez-Izquierdo D, Buchonnet G, Siebert R, Gascoyne RD, Climent J, Karran L, Marin M, Blesa D, Horsman D, Rosenwald A, Staudt LM, Albertson DG, Du MQ, Ye H, Marynen P, Garcia-Conde J, Pinkel D, Dyer MJ, Martinez-Climent JA.

Blood. 2003 Jun 1;101(11):4539-46. Epub 2003 Jan 30.

10.

Genomic loss of 18p predicts an adverse clinical outcome in patients with high-risk breast cancer.

Climent J, Martinez-Climent JA, Blesa D, Garcia-Barchino MJ, Saez R, Sánchez-Izquierdo D, Azagra P, Lluch A, Garcia-Conde J.

Clin Cancer Res. 2002 Dec;8(12):3863-9.

Supplemental Content

Loading ...
Support Center